Advertisement
ProteinSimple
ProteinSimple

Neurologist Reveals Insider Information

A Michigan University clinical researcher allegedly supplied a fund manager with information about drug trial results that the fund used to rake in more than $270 million.

By | November 26, 2012

Flickr, jollyUKSidney Gilman, former chair of the neurology department at the University of Michigan Medical School, has been sued by federal authorities for providing a hedge fund information about clinical trials for an Alzheimer’s drug under development by Elan and Wyeth that led to the fund dumping stocks and making more than $270 million.

The man at the head of the investigation is Mathew Martoma, a portfolio manager at hedge fund firm SAC Capital Advisors, although prosecutors are also looking into wrongdoing by the company’s owner Steven Cohen. Martoma is charged with making trades based on information from Gilman. 

 Preet Bharara, the United States attorney who brought the case to court, called the transaction “the most lucrative insider trading scheme ever charged,” in an interview with The New York Times.

Gilman, who is 80, served as a consultant to Martoma, receiving nearly $108,000 for his expertise.  He also helped oversee the Alzheimer’s trial and is accused of providing information regarding, at first, the drug’s positive results, and later, it’s failure, allowing Martoma to invest and pull out at the right times. Lawyers have promised not prosecute Gilman in exchange for his cooperation. However, Gilman may still face disciplinary action by the University of Michigan, who is reviewing the neuroscientist’s actions as a consultant and waiting to hear what additional information is uncovered during the trial.

(Hat tip to ScienceInsider)

Correction (November 26, 2012): Sidney Gilman is a former chair of the neurology department at the University of Michigan Medical School, rather than a current chair, as was written.  The Scientist regrets the error.

Advertisement

Add a Comment

Avatar of: You

You

Processing...
Processing...

Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo

Comments

Avatar of: BobD

BobD

Posts: 20

November 26, 2012

Dr. Gillman may have just bumped Martha Stewart off the "Clueless Insider Trading Hall of Fame."

Advertisement
EMD Millipore
EMD Millipore

Popular Now

  1. Antibody Alternatives
    Features Antibody Alternatives

    Nucleic acid aptamers and protein scaffolds could change the way researchers study biological processes and treat disease.

  2. The Mycobiome
    Features The Mycobiome

    The largely overlooked resident fungal community plays a critical role in human health and disease.

  3. Circadian Clock and Aging
    Daily News Circadian Clock and Aging

    Whether a critical circadian clock gene is deleted before or after birth impacts the observed aging-related effects in mice.

  4. Biologist Resigns Amid Sexual Misconduct Probe
Advertisement
INTEGRA
INTEGRA
Advertisement
Life Technologies